Skip to main content
Peter Gottlieb, MD, Endocrinology, Aurora, CO, University of Colorado Hospital

PeterGottliebMD

Endocrinology Aurora, CO

Diabetes, Lipid Metabolism

Professor, Pediatrics, University of Colorado School of Medicine

Dr. Gottlieb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gottlieb's full profile

Already have an account?

Summary

  • Dr. Peter Gottlieb is an endocrinologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital and Children's Hospital Colorado. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 33 years. He specializes in diabetes and lipid metabolism and is experienced in diabetes mellitus, chronic adrenal insufficiency, and autoimmune disease.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1984 - 1987
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1984

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1994 - 2025
  • MA State Medical License
    MA State Medical License 1986 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes  
    Peter Gottlieb, MD, Diabetes Care
  • Learning from Past Failures of Oral Insulin Trials  
    Peter A Gottlieb, Aaron W Michels, Diabetes Care

Press Mentions

  • New Therapy First to Target Type 1 Diabetes Disease Process
    New Therapy First to Target Type 1 Diabetes Disease ProcessApril 17th, 2023

Hospital Affiliations